Graphite Bio Investor Relations Material
Latest events
M&A Announcement
Graphite Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Graphite Bio Inc
Access all reports
Graphite Bio Inc is a biotechnology company engaged in the development of gene editing therapies for the treatment of serious genetic diseases. Its research focuses on employing precise DNA repair mechanisms to create targeted and durable treatments. The company primarily serves the healthcare and pharmaceutical sectors. Graphite Bio Inc is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
GRPH
Country
🇺🇸 United States